Determination and clinical correlation of markers of inflammation in unvaccinated patients with varicella-zoster infection

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 15, 2013, Pages 2032-2039

  Karadag Oncel, E ^a   Kara, A ^a   Celik, M ^a   Karahan, S ^a   Cengiz, A B ^a   Ceyhan, M ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute phase reactants; Children; IL 6; TNF alpha; Varicella; Zoster

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CHICKENPOX VACCINE;

ADOLESCENT; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; CHICKENPOX; CHILD; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFANT; INFLAMMATION; LABORATORY TEST; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; SKIN DEFECT; BLOOD; METABOLISM;

ADOLESCENT; BIOLOGICAL MARKERS; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HERPES ZOSTER; HUMANS; INFANT; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884240795     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ARVIN AM. Varicella-zoster virus. Clin Microbiol Rev 1996; 9: 361-381. (Pubitemid 26245616)
2. HEININGER U, SEWARD JF. Varicella. Lancet 2006 14; 368:1365-1376. (Pubitemid 44540319)
3. WELLER TH, WITTON HM, BELL EJ. The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro. J Exp Med 1958; 108: 843-868.
4. GALIL K, BROWN C, LIN F, SEWARD J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J 2002; 21: 931-935.
5. DAVIS MM, PATEL MS, GEBREMARIAM A. Decline in varicellarelated hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114: 786-792. (Pubitemid 41529540)
6. SCHULTZ C, ROTT C, TEMMING P, VON PUTTKAMMER J, BUCSKY P. Influence of specimen age and use of different negative controls in determination of intracytoplasmic levels of cytokines after wholeblood culture assay. Clin Diagn Lab Immunol 2002; 9: 295-298. (Pubitemid 34226020)
7. BRISSON M, EDMUNDS WJ, LAW B, GAY NJ, WALLD R, BROWNELL M, ROOS L, DE SERRES G. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001; 127: 305-314. (Pubitemid 33019542)
8. BOELLE PY, HANSLIK T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect 2002; 129: 599-606. (Pubitemid 36157685)
9. RATNER AJ. Varicella-related hospitalizations in the vaccine era. Pediatr Infect Dis J 2002; 21: 927-930. (Pubitemid 35176152)
10. SEWARD JF, ZHANG JX, MAUPIN TJ, MASCOLA L, JUMAAN AO. Contagiousness of varicella in vaccinated cases, a household contact study. JAMA 2004: 292: 704-708. (Pubitemid 39062524)
11. WHARTON M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996; 10: 571-581. (Pubitemid 26285287)
12. FAIRLEY CK, MILLER E. Varicella-zoster virus epidemiology- A changing scene? J Infect Dis 1996; 174: 314-319.
13. YAWN BP, YAWN RA, LYDICK E. Community impact of childhood varicella infections. J Pediatr 1997; 130: 759-765. (Pubitemid 27492614)
14. KANRA G, TEZCAN S, BADUR S, TURKISH NATIONAL STUDY TEAM. Varicella seroprevalence in a random sample of the Turkish population. Vaccine 2002; 20: 1425-8. (Pubitemid 34131685)
15. ROSS AM, FLEMING DM. Chickenpox increasingly aff ects preschool children. Commun Dis Public Health 2000; 3: 213-215.
16. SOCAN M, KRAIGHER A, PAHOR L. Epidemiology of varicella in Slovenia over a 20-year period (1979- 1998). Epidemiol Infect 2001; 126: 279-283. (Pubitemid 32454740)
17. THOMAS SL, HALL AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004; 4: 26-33. (Pubitemid 38057055)
18. BOWDEN RA, LEVIN MJ, GILLER RH, TUBERGEN DG, HAYWARD AR. Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients. Clin Exp Immunol 1985; 60: 387-389.
19. IHARA T, KATO T, TORIGOE S, OITANI K, ISAJI M, ITO M, KAMIYA H, SAKURA M. Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization. Acta Paediatr Jpn 1991; 33: 43-49.
20. ITO M, BANDYOPADHYAY S, MATSUMOTO-KOBAYASHI M, CLARK SC, MILLER D, STARR SE. Interleukin 2 enhances natural killing of varicella-zoster virus-infected targets. Clin Exp Immunol 1986; 65: 182-189. (Pubitemid 16062995)
21. MIKAELOFF Y, KEZOUH A, SUISSA S. Nonsteroidal antiinflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol 2008; 65: 203-209. (Pubitemid 351171264)
22. ZERR DM, ALEXANDER ER, DUCHIN JS, KOUTSKY LA, RUBENS CE. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999; 103: 783-790. (Pubitemid 29274472)
23. LESKO SM, O'BRIEN KL, SCHWARTZ B, VEZINA R, MITCHELL AA. Invasive group A streptococcal infection and nonsteroidal anti-inflammatory drug use among children with primary varicella. Pediatrics 2001; 107: 1108-1115. (Pubitemid 32440619)